Language selection

Search

Patent 2218376 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2218376
(54) English Title: CATHETER FOR ADMINISTERING A LIQUID AGENT
(54) French Title: CATHETER POUR ADMINISTRER UN AGENT LIQUIDE
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61M 25/00 (2006.01)
  • A61M 25/14 (2006.01)
(72) Inventors :
  • MCALISTER, GARY B. (United States of America)
  • SULLIVAN, ROY H., III (United States of America)
  • WARICH, CHARLES B. (United States of America)
(73) Owners :
  • BOSTON SCIENTIFIC LIMITED (Barbados)
(71) Applicants :
  • BOSTON SCIENTIFIC CORPORATION (United States of America)
(74) Agent: SMART & BIGGAR
(74) Associate agent:
(45) Issued: 2006-08-08
(86) PCT Filing Date: 1996-05-06
(87) Open to Public Inspection: 1996-11-07
Examination requested: 2003-04-25
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1996/006335
(87) International Publication Number: WO1996/034645
(85) National Entry: 1997-10-16

(30) Application Priority Data:
Application No. Country/Territory Date
08/434,242 United States of America 1995-05-04

Abstracts

English Abstract




A catheter (10) for the administration of a liquid agent at a target site
includes a catheter tube (11), a handle (12) and a conduit (13)
that extends through a central volume formed in the handle. The catheter
includes a guidewire lumen (22) and two parallel liquid agent
transfer lumens (23 24). The conduit seals into the proximal end of the
guidewire lumen and to the handle at a first entry port (30) and
spans the central volume. The tube therefore prevents the transfer of any
liquid agent into the guidewire lumen and provides a passageway
for enabling the catheter to transfer over the guidewire. With two transfer
lumens the catheter tube provides a maximum transfer flow rate
while maintaining the ability of the catheter to resist kinking and bending.




French Abstract

L'invention concerne un cathéter (10) pour l'administration d'un agent liquide au niveau d'un site cible. Ce cathéter comporte un tube (11), un manche (12) et un conduit (13) qui traverse un volume central formé dans le manche. Ce cathéter comprend un canal intérieur (22) destiné au fil-guide et deux canaux intérieurs parallèles (23, 24) destinés au transfert de l'agent liquide. Le conduit assure l'étanchéité vis-à-vis de l'extrémité proximale du canal intérieur destiné au fil-guide et vis-à-vis du manche au niveau d'un premier orifice d'entrée (30), et traverse le volume central. Le tube empêche donc tout transfert d'agent liquide dans le canal intérieur destiné au fil-guide et assure un passage permettant au cathéter de glisser sur le fil-guide. Avec ces deux canaux intérieurs de transfert, le tube du cathéter assure un débit de transfert maximal tout en maintenant l'aptitude du cathéter à résister au coquage et au pliage.

Claims

Note: Claims are shown in the official language in which they were submitted.





-11-


Claims


1. A catheter for the administration of a liquid agent
at a target site within a patient comprising:

(A) a catheter tube terminating in proximal and
distal ends and having first, second and third
lumens extending therethrough and exiting
through the proximal and distal ends, said
distal end being adapted for location at the
target site,

(B) a handle having a central volume and first and
second entry ports and a catheter port extending
between the exterior of said handle and said
central volume, the proximal end of said
catheter tube being affixed in said catheter
port whereby liquid agent administered through
said second port to said central volume
transfers through said second and third lumens
to the distal end for ejection at the target
site,

(C) a conduit extending through said central volume
and having one end terminating in said first
lumen at the proximal end of said catheter tube
and the other end terminating in said first
entry port thereby to prevent the transfer of
liquid agent from said central volume into said
first lumen.

2. A catheter for the administration of a liquid agent
as recited in claim 1 wherein said conduit is a thin-
walled tube.

3. A catheter for the administration of a liquid agent
as recited in claim 2 wherein said thin-walled tube
is formed of stainless steel.

4. A catheter for the administration of a liquid agent
as recited in claim 2 wherein the area of said first
lumen in cross section exceeds the area in cross
section of each of said second and third lumens.







-12-


5. A catheter for the administration of a liquid agent
as recited in claim 4 wherein each of said first,
second and third lumens is circular in cross section.

6. A catheter for the administration of a liquid agent
as recited in claim 5 wherein said first lumen is
sized to receive a medical guidewire and said second
and third lumens collective have an area in cross
section that is approximately 25% of the area of said
first lumen in cross section.

7. A catheter for the administration of a liquid agent
as recited in claim 2 wherein said first entry port
and said catheter port are spaced along a first axis
and wherein said thin-walled tube is coaxial with the
first axis and said second entry port extends along a
second axis transverse to the first axis.

8. A catheter for the administration of a liquid agent
as recited in claim 7 additionally comprising
gripping means formed on the exterior of said handle
for facilitating the use of said catheter.

9. A catheter for the administration of a liquid agent
as recited in claim 8 wherein the first and second
entry port axes define a plane and said gripping
means comprises spaced planar portions formed
integrally with said handle in parallel with and
spaced from the plane defined by the entry port axes.

10. An ERCP cannula for administering a contrast agent in
the biliary tree within a patient comprising:

(A) a catheter tube terminating in proximal and
distal ends and having a guidewire lumen and
first and second transfer lumens formed between
the proximal and distal ends,

(B) a handle with a first entry port and a catheter
port spaced along a first axis, a second entry
port extending along a second axis that is
transverse to the first axis and a central
volume coextensive with portions of the first
and second axes,







-13-


(C) a thin-walled tube extending along the first
axis through said central volume, one end of
said tube being sealed to said first entry port
and the other end of said tube being located in
the guidewire lumen of said catheter tube in a
sealed relationship with said catheter tube, and

(D) an outer seal formed about portions of the
exterior of said handle at said catheter port
and about portions of the exterior of catheter
tube extending from said handle adjacent
thereto.

11. An ERCP cannula for the administration of a contrast
agent in the biliary tree as recited in claim 10
wherein said catheter tube comprises an extruded TFE
material, said handle is formed of molded nylon and
said thin-walled tube is composed of stainless steel.

12. An ERCP cannula for the administration of a contrast
agent in the biliary tree as recited in claim 11
wherein said outer seal comprises a heat-shrinkable
material.

13. An ERCP cannula for the administration of a contrast
agent in the biliary tree as recited in claim 11
wherein said catheter tube is tapered at the distal
end and wherein said lumens are tapered
correspondingly.

14. An ERCP cannula for the administration of a contrast
agent in the biliary tree as recited in claim 11
additionally comprising spaced markers adjacent the
distal end of said catheter tube.

15. An ERCP cannula for the administration of a contrast
agent in the biliary tree as recited in claim 11
additionally comprising an end cap for closing said
first entry port, said first entry port including
means for securing said end cap to said handle.




Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02218376 1997-10-16
W~ 96/34645 PCT/US96/06335
-1-
Background of the Invention
Catheter For Administering' A Liquid Aft
Technical Field
This invention generally relates to catheters for use
in enabling the visualization of the anatomy and more
specifically to catheters that are particularly adapted
for the field of endoscopic retrograde
cholangiopancreatography.
Background Art
The use of catheter-like devices for administering
therapeutic, diagnostic and vaso-occlusive agents at
predetermined target sites in a patient is well known.
Initially catheters of this type, particularly for use in
the field of endoscopic retrograde
cholangiopancreatography (ERCP) procedures, were
constructed from Teflon~ and included a single lumen sized
to accommodate a wire guide and to act as a liquid agent
transfer channel. As the ERCP catheters typically were
also adapted to be inserted over guidewires or through
working channels of endoscopes, they were typically
shipped with a stylet wire in the lumen that would stiffen
the catheter to prevent kinking or bending. The stylet
had to be removed prior to any use of the catheter with a
guidewire or after the catheter was inserted through an
endoscopic device.
The presence of a guidewire in the lumen may restrict
the transfer of liquid agents, such as radiographic
contrast agents, through the lumen past the guidewire.~
Consequently after a physician inserted the ERCP catheter,
any guidewire would be removed to facilitate the
administration of a radiopaque contrast agent to determine
the location of various obstructions.
Often times it became necessary to reposition the
catheter. This required the reinsertion of the guidewire
through the lumen to enable catheter relocation. Then it
was necessary to remove the guidewire again. The need to
maintain sterile conditions further complicated this
procedure especially as to the guidewire while it was

CA 02218376 1997-10-16
WO 96/34645 PCT/US96/06335
-2-
removed from the catheter. Given the nature of the
contrast agents, it was also found that in some cases the
contrast agent, guidewire and lumen in combination can
become stiff thereby reducing catheter flexibility. In
some situations it was even possible for the guidewire to
stick in the catheter thereby requiring the removal of
both the catheter and the guidewire. Single lumen
catheters also were characterized by back flow whereby the
contrast agent could squirt back out the proximal end of
the catheter and onto the administering medical
professional.
More recently there have been introduced dual lumen
ERCP catheters in which one of the lumens is adapted for
receiving a guidewire or stylet and the other is adapted
for transferring the contrast agent. The transfer lumen
has typically either had a circular cross-section or
crescent-shaped cross-section, the latter being disclosed,
for example, in United States Letters Patent No. 5,397,302
to Weaver. In the Weaver patent a catheter formed of
2o polyurethane or nylon has a durometer of about 60D and a
hydrophilic coating thereby to provide lubricity, kink
resistance and suppleness. The catheter tube has
substantially cylindrical side walls, a proximal end for
connection to a source of contrast medium and a distal end
for entry into the common biliary duct of a patient. The
tube contains a first crescent-shaped liquid agent
transfer lumen for transporting contrast media from the
source of the contrast medium to the biliary duct. A
second circular lumen facilitates the insertion of the
catheter over a guidewire.
Although dual-lumen catheters of the prior art
eliminate many of the handling problems posed by single
lumen catheters, in terms of removing and reinserting a
stylet or guidewire, several undesirable characteristics
still exist. For example, dual lumen catheters for ERCP
procedures are limited to a maximum overall diameter. The
addition of a second lumen of sufficient size to provide
adequate transfer rates through the catheter of that

CA 02218376 1997-10-16
WU 96/34645 PCT/LTS96/06335
-3-
maximum size can weaken the catheter wall and subject the


catheter to being burst while a contrast agent is being


administered. Further, even if some minimum wall


thickness is maintained to prevent bursting, a catheter


being inserted through an endoscope without a guidewire is


' subject to kinking and bending under the axial pressure


required to move the catheter relative to the endoscope.


Kinking and bending have a real potential for damage to


the catheter. Consequently physicians oftentimes will


become quite deliberate and even tentative in advancing a


catheter as the transfer force increases in order to avoid


kinking or bending with the subsequent requirement that


the catheter be withdrawn and destroyed. Consequently


even dual lumen catheters typically include a stiffening


stylet for use with endoscopic devices. Still further,


these constraints on the size of the second lumen can, for


reasonable pressures exerted on the liquid agent, limit


flow rate through the lumen to an unacceptably low value.


Disclosure of Invention


Therefore it is an object of this invention to


provide a catheter for the administration of a liquid


agent at a target site that is characterized by improved


flow through the catheter.


Another object of this invention is to provide a


catheter for the administration of a liquid agent at a


target site that is characterized by improved flow through


the catheter and by separation of the paths for the liquid


agent and a guidewire.


Still another object of this invention is to provide


a catheter for the administration of a liquid agent at a


target site that can be led through an endoscopic device


without the need for a stiffening stylet.


Yet another object of this invention is to provide a


catheter for the administration of a liquid agent at a


'target site that can be led through an endoscopic device
without buckling or kinking.
Still yet another object of this invention is to
provide a catheter adapted for use in endoscopic

CA 02218376 1997-10-16
WO 96/34645 PCT/US96/06335
-4-
retrograde cholangiopancreatography procedures that
includes separate lumens for a guidewire and for the
transfer of a contrast agent from a proximal site to a
distal site.
In accordance with one aspect of this invention a
catheter for the administration of a liquid agent at a
target site within a patient comprises a catheter tube, a
handle and a conduit. The catheter tube includes first,
second and third lumens that extend through the catheter
tube and exit through a proximal end and a distal end that
is adapted for transit to a target site. The handle has
first and second entry ports and a catheter port, each
port extending between the exterior of the handle and a
central volume. The proximal end of the catheter tube is
affixed in the catheter port such liquid agent
administered under pressure through the second port
transfers through the second and third lumens in parallel
to the distal end for ejection at the target site. The
conduit extends through the central volume and has one end
terminating at the first lumen at the proximal end of the
catheter tube and the other end terminating in the first
entry port thereby to prevent the transfer of liquid agent
from the central volume into the first lumen.
In accordance with another aspect of this invention,
an ERCP cannula for administering a contrast agent in the
biliary tree comprises a catheter tube, a handle, a thin-
walled tube and an outer seal. The catheter tube has a
guidewire lumen and first and second transfer lumens
formed between a proximal end and a distal end that is
adapted for location in the biliary tree. The first and
second transfer lumens have a combined area in cross-
section of approximately 25% of the area in cross-section
of the guidewire lumen. The handle includes a first entry
port and a catheter port spaced along a first axis, a
second entry port extending along a second axis that is
transverse to the first axis and a central volume
coextensive with portions of the first and second axes.
The thin-walled tube extends along the first axis through

CA 02218376 1997-10-16
WO 96/34645 PCT/LTS96/06335
-5-
the central volume. One end of the tube is sealed to the


first entry port, and the other end of the tube is sealed


against the catheter tube in the guidewire lumen. The


outer seal is formed about portions of the exterior of the


handle at the catheter port and portions of the exterior


of the catheter extending from the catheter tube.


Brief Description of the Drawings


The appended claims particularly point out and


distinctly claim the subject matter of this invention.


The various objects, advantages and novel features of this


invention will be more fully apparent from a reading of


the following detailed description in conjunction with the


accompanying drawings in which like reference numerals


refer to like parts, and in which:


FIG. 1 is a plan view of a catheter constructed in


accordance with this invention;


FIG. 2 is a view, in cross-section, of a portion of


the catheter shown in FIG 1;


FIG. 3 is a view, in cross-section, taken along lines


3-3 in FIG 2; and


FIG. 4 is an enlarged view, in cross-section, taken


along lines 4-4 in FIG. 1.


Best Mode for Carrying Out the Invention


As shown particularly in FIGS. 1 and 2, a catheter 10


for the administration of a liquid agent at a target site


within a patient includes a catheter tube 11, a handle 12,


a conduit 13, a seal 14 and an end cap 15. The catheter


tube 11 extends between a proximal end 16 and a distal end


17. A section 18 of the catheter tube 11 adjacent the


distal end 17 has a reduced diameter that terminates in a


tapered tip portion 20. The reduced diameter section 18


carries a series of visual and radiographic markers 21.


The reduction of the catheter tube diameter, the taper of


the distal tip 20 and utilization of such radiographic


markers 21 is well known in the art.


FIG. 3 depicts the construction of the catheter tube


in accordance with this invention looking at the proximal


end 16 while FIG. 4 depicts a cross-section through the



CA 02218376 1997-10-16
WO 96/34645 PCT/TTS96l06335
-6-
tapered tip 20. The tube 11 can be formed of TFE or other
known biocompatible materials useful in catheter
construction. Typically the catheter tube 11 is extruded
Y
according to known methods to produce three lumens that
exit through the proximal end 16 and the distal end 17. A
first lumen 22 accommodates a guidewire. A second lumen
23 and third lumen 24 act a liquid transfer conduits for
conveying a contrast or other liquid agent from the handle
12 in FIG. 1 to the distal end 17.
For ERCP cannula applications, the catheter tube 11
may have a diameter of about 0.10". In such an embodiment
the first lumen has a diameter at the proximal end of
about 0.039" to accommodate a standard 0.035" guidewire.
Each of the lumens 23 and 24 has a diameter of about
0.020". Approximately 75% of a solid cylinder having the
diameter of the catheter 11 remains after the extrusion of
the three lumens 22 through 24.
Referring to FIG. 4, the material remaining after
forming the first lumen 22 and the second and third lumens
23 and 24 defines an outer ring 25 denoted generally by a
dashed line and three interconnected, generally radially
extending ribs designated by reference numerals 26, 27 and
28. The ribs 26 through 28 and the outer ring 25 form a
column structure that resists kinking and bending when
axial thrust is applied to the catheter tube 11 such as
thrust along the axis 30 shown in FIGS. 1 and 2. It has
been found that a catheter 10 with this catheter tube .
structure can be led through the working channel of an
endoscope without kinking or bending and without the
addition of a stylet. Thus a stylet can be eliminated to
simplify the use of and reduce the cost of the catheter
10.
As is known, after the extrusion of the tube 11
forming the lumens 22 through 24, the reduced diameter
portion 18 and tapered tip portion 20 are formed by
drawing the corresponding portions of the catheter tube 11
through a reducing die with mandrels located in each
lumen. Consequently any reduction in the overall diameter

CA 02218376 1997-10-16
WO 96/34645 PCT/US96/06335
_7_
need not significantly reduce the size of any lumens, so


the lumen 22, for example, still accommodates a standard


guidewire. Thus, in accordance with this construction,


' each of the lumens 22 through 24 exits through the distal


end 17 of the catheter device 11 and provides a passage 22


' for the guidewire and two passages 23 and 24 for the


administration of a contrast agent.


Referring now to FIGS. 1 and 2, the handle 12


includes a first entry port 30, a second entry port 31, a


catheter port 32 and an internal central volume or chamber


33. Both the first and second entry ports form


Conventional portions of Leur lock fittings. Referring


specifically to FIG. 2, the central volume 33 has a


generally cylindrical shape lying along the extension of


the catheter axis 30. The first entry port 30 and the


catheter port 32 are coaxial with the axis 30. A portion


of the catheter tube 11 adjacent the proximal end 16 lies


in the catheter port 32 with the outer surface of the


catheter tube 17 being sealed to the portions of the


handle 12 forming the catheter port 32.


Still referring to FIGS. 2 and 3, there is also


included in the handle 12 a conduit 36 in the form of a


thin-walled stainless steel tube, or "hypotube". one end


portion 37 of the conduit 36 extends into the first lumen


22 and produces a seal between the outer surface of the


conduit 36 and the inner surface of the catheter tube 11


forming the lumen 22. The other end portion 38 of the


tube 36 is sealed to the handle 12 at the entry port 30.


The volume of the chamber 33 is selected so that the total


cross-sectional area of the central volume 33 minus the


area of the tube 36 is at least as great as the combined


areas of the lumens 22 and 24.


The second entry port 31 lies along an axis 34 that


extends at right angles to the axis 33. The port 31


provides access to the central volume through a transverse


passage 35.


As will now be apparent, the tube 36, that is coaxial


with the axis 30, provides an isolated path for a



CA 02218376 1997-10-16
WO 96134645 PCT/US96/06335
_g_
guidewire that extends from the first port 30 through the
tube 36 and the first lumen 22. As contrast agent is
administered through the second entry port 34 under
pressure, it transfers through the passage 35 into the
central volume 33 around the tube 36. Given the seal
between the tube 36 and the catheter tube 11, this
material can not enter the lumen 22, but instead flows
only through the lumens 23 and 24 to be ejected at the
distal end 17 as shown in FIG. 1.
When a physician uses the catheter 10 in a procedure
requiring a guidewire, a physician first positions the
guidewire in the patient and then threads the distal tip
17 over the proximal end of the guidewire such that the
guidewire travels through the lumen 22 and the distal tip
20 moves to a target site. The radiographic markers 21
provide a means for determining the position of the distal
tip 17 during the location process.
Without removing the guidewire, the physician then
can attach a syringe or other device to the second entry
port 31 and force a contrast agent through the passage 35,
the central volume 33 and the lumens 23 and 24 in parallel
to be discharged where the lumens 23 and 24 exit the
distal end 17. The seals formed between the tube 36 and
the handle 12 and between the tube 36 and the catheter
tube 11 around the guidewire 22 assure isolation of the
guidewire lumen 22. Thus if it is necessary to relocate
the distal tip 20, there is no need to remove the
guidewire.
When the guidewire is in place, the free volume
around the guidewire 22 in the lumen 22 is sufficiently
small that any transfer of contrast agent back through the
lumen 22 as it is discharged from the distal end 17 is
blocked. When the catheter 10 shown in FIG. 1 is used
with an endoscopic device and without a guidewire, the
lumen 22 constitutes a path of low flow resistance to the
contrast agent as it exits the distal end 17 through the
lumens 23 and 24. In such procedures, the end cap 15 can
be attached to the first entry port 30 effectively sealing

CA 02218376 1997-10-16
WO 96/34645 PCT/US96/06335
_g_
the lumen 22. The end cap 15 is a typical Luer lock end


cap as known in the art. Should any contrast agent begin


to enter the lumen 22 at the distal end 17, any air in the


lumen 22 will compress and eventually reach an equilibrium


pressure whereby further displacement along the lumen 22


will not occur. Thus, the use of the end cap 15 overcomes


the prior art problem of having contrast agent flowing


back through the lumen 22 onto the personnel administering


the fluid.


Referring again to FIGS. 1 and 2, one particular


embodiment of the seal 14 comprises a two-part structure


with each part. being formed of a heat shrinkable material


such as polyolefin. A first seal 40 is formed onto a


circumferential band 41 formed integrally with the handle


12 at the catheter port 32 to improve a mechanical
i


gr
p


with the seal 40. The remaining portion of the seal 40


extends distally along the outer surface of the catheter


tube 11 for some predetermined distance to an end 41. A


- second heat shrinkable tube 42 can be applied over the


first tube 40 to terminate at an end 43 such that a small


portion of the tube 40 is exposed distally of the end 43.


In a preferred embodiment, the two tubes are formed of


different colors so the exposed portion of the tube 40


provides a marking function for facilitating measurements


during an ERCP procedure.


Therefore in accordance with the various aspects of


this invention, there has been disclosed a catheter for


the administration of liquid agents at a target site in a



patient, particularly contrast agents for use in ERCP


procedures, that includes a three-lumen catheter tube
a


,


handle and a thin-walled tube that is sealed in the


proximal end of a guidewire lumen in the catheter tube.


The proximal end of the catheter tube and the thin-walled


tube extending from the catheter tube are inserted into


a


catheter port of a handle with the other end of the thin-


walled tube being sealed to the handle at a first entry


port thereby to provide passage for a standard guidewire


through the first entry port the tube and the first lumen.



CA 02218376 1997-10-16
WO 96/34645 PCT/US96/06335
-10-
A second entry port also communicates with the central
chamber to provide a path for contrast agent through the
central volume and second and third lumens to the distal
end through the catheter tube. The combination of the
thin-walled tube and the central volume isolate the
guidewire lumen from the liquid transfer lumens thereby to
prevent the transfer of contrast agent into the guidewire
lumen so that a guidewire operates freely even during
repeated operations.
This structure eliminates the steps of removing a
guidewire during successive operations because there is a
separate path for the contrast agent. When the catheter
is used in endoscopic devices, its cross-section enables
the catheter to be inserted through the endoscope working
channel without a stylet.
This invention has been described in terms of a
particular embodiment in which the various components of
the catheter have specific configurations and dimensions
and are composed of particular materials. It will be
apparent that this invention could be embodied in
alternative structures and having different dimensions and
formed of different materials. For example, the thin-
walled tube that isolates the guidewire lumen from the
remaining lumens is shown along a straight axis, this axis
might be formed within an angular offset if desired.
Therefore, it is the intent of the appended claims to
cover all such variations and modifications as come within
the true spirit and scope of this invention.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2006-08-08
(86) PCT Filing Date 1996-05-06
(87) PCT Publication Date 1996-11-07
(85) National Entry 1997-10-16
Examination Requested 2003-04-25
(45) Issued 2006-08-08
Deemed Expired 2013-05-06

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 1997-10-16
Application Fee $300.00 1997-10-16
Maintenance Fee - Application - New Act 2 1998-05-06 $100.00 1998-04-23
Maintenance Fee - Application - New Act 3 1999-05-06 $100.00 1999-04-20
Maintenance Fee - Application - New Act 4 2000-05-08 $100.00 2000-03-22
Maintenance Fee - Application - New Act 5 2001-05-07 $150.00 2001-03-23
Maintenance Fee - Application - New Act 6 2002-05-06 $150.00 2002-03-22
Maintenance Fee - Application - New Act 7 2003-05-06 $150.00 2003-03-19
Request for Examination $400.00 2003-04-25
Maintenance Fee - Application - New Act 8 2004-05-06 $200.00 2004-03-16
Registration of a document - section 124 $100.00 2004-07-09
Maintenance Fee - Application - New Act 9 2005-05-06 $200.00 2005-03-14
Maintenance Fee - Application - New Act 10 2006-05-08 $250.00 2006-03-20
Final Fee $300.00 2006-05-23
Maintenance Fee - Patent - New Act 11 2007-05-07 $250.00 2007-04-10
Maintenance Fee - Patent - New Act 12 2008-05-06 $250.00 2008-04-07
Maintenance Fee - Patent - New Act 13 2009-05-06 $250.00 2009-04-07
Maintenance Fee - Patent - New Act 14 2010-05-06 $250.00 2010-04-07
Maintenance Fee - Patent - New Act 15 2011-05-06 $450.00 2011-04-18
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BOSTON SCIENTIFIC LIMITED
Past Owners on Record
BOSTON SCIENTIFIC CORPORATION
MCALISTER, GARY B.
SULLIVAN, ROY H., III
WARICH, CHARLES B.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 1998-02-02 1 12
Abstract 1997-10-16 1 50
Description 1997-10-16 10 517
Claims 1997-10-16 3 131
Drawings 1997-10-16 2 38
Cover Page 1998-02-02 1 57
Representative Drawing 2006-07-11 1 12
Cover Page 2006-07-11 1 47
Assignment 1997-10-16 11 409
PCT 1997-10-16 6 224
Prosecution-Amendment 2003-04-25 1 38
Prosecution-Amendment 2003-06-13 1 36
Assignment 2004-07-09 3 92
Correspondence 2006-05-23 1 37